Viyash Scientific ESOP Allotment: 2,28,408 Shares Issued
NiveshIQ
NSE: VIYASH · Healthcare
Viyash Scientific Ltd.
₹220.31▲ ₹1.92 (+0.88%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on VIYASH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Viyash Scientific Ltd.
Viyash Scientific Limited, headquartered in Hyderabad, operates as a veterinary pharmaceutical company with a presence in India, the United States, Spain, and other international markets. The company’s core business spans active pharmaceutical ingredient (API) manufacturing, finished dosage formulations, analytical services, and veterinary formulation services for cattle and poultry. In Q2 2026, Viyash reported revenue of ₹3,575 crore and a net income of ₹211 crore, reflecting steady profitability in a niche segment of animal health. Recent strategic moves include a ₹188 crore acquisition of BioForLife Italia, expanding its European footprint and product portfolio. The firm also announced an ESOP share allotment in October 2026 to attract and retain talent. Viyash’s competitive position is
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,370 Cr -3.60% | ₹1,551 Cr +13.26% | ₹3,420 Cr +120.47% |
| EBITDA Margin | 4.48% | 10.43% | 19.08% |
| Net Profit | -75.40% | ₹21.88 Cr -323.30% | ₹177.28 Cr +710.24% |
| EPS | ₹-1.44 | ₹0.88 | ₹4.09 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Viyash Scientific incorporates Vietnam subsidiary
Viyash Scientific Ltd is Rated Hold by MarketsMOJO
🔒
+ 3 more stories about Viyash Scientific Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹946 Cr, PAT ₹66 Cr, EPS ₹1.51, EBITDA margin 18.8%. Growth context: revenue YoY +114.4%, PAT YoY +360.3%, revenue QoQ +2.9%, PAT QoQ +26.4%. Street verdict: miss.
Management highlights product launches, approvals, therapy‑mix improvement, order wins, deal pipeline, and backlog build...
FY26 (last completed FY): revenue ₹3, 420 Cr, PAT ₹177 Cr, EBITDA margin 19.1%, EPS ₹4.09. Year-on-year: revenue YoY +12...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for VIYASH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track VIYASH alongside your other holdings
Unlock full VIYASH research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Viyash Scientific Ltd.?
NiveshIQ detects active intelligence signals for Viyash Scientific Ltd. (VIYASH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Viyash Scientific Ltd.?
Viyash Scientific Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,120,008.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.